We complementarily analysed the frequency of CA in human breast carcinomas from the different PAM50 molecular subtypes, comprising 29 luminal A, 3 luminal B, 3 HER2 and 13 basal-like tumours (Fig 2i and S4 Table). This evidence concerns the gene ERBB2 and breast carcinoma.